Jeff Yass’s Allogene Therapeutics ALLO Stock Holding History
Bought
Maintained
Sold
Other funds holding ALLO
Jeff Yass's ALLO Position: Q3 2026 in Review
Jeff Yass increased its Allogene Therapeutics (ALLO) stake by 147% in Q3 2026, buying an estimated $262K and bringing the position to 231,290 shares worth $370K. The position accounts for ﹤0.01% of the portfolio, ranked #10469.
Jeff Yass first reported a position in ALLO in Q2 2019 and has held it in 29 quarters since. The position peaked at $5.44M in Q1 2021. 196 funds tracked by Wall St. Rank hold ALLO as of Q3 2026.
- Jeff Yass held 231,290 shares of Allogene Therapeutics worth $370K as of Q3 2026.
- Jeff Yass bought 137,649 Allogene Therapeutics shares in Q3 2026, an estimated $262K.
- Allogene Therapeutics made up ﹤0.01% of Jeff Yass's portfolio in Q3 2026, its #10469 holding.
- Jeff Yass first reported a position in Allogene Therapeutics in Q2 2019 and has held it in 29 quarters since.
- Jeff Yass's Allogene Therapeutics position peaked at $5.44M in Q1 2021.
- 196 funds tracked by Wall St. Rank held Allogene Therapeutics as of Q3 2026.
Based on Susquehanna International Group's 13F filing for Q3 2026, filed 16 Nov 2026.